Post-Marketing Clinical Follow-Up of a Spine Implant

NCT ID: NCT03180749

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-02

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-Marketing Clinical Follow-up of an Anular Closure System (Barricaid®) to Confirm Comparability of Outcome between Devices with Subcomponents from Two Different Suppliers

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Comparison of device integrity (anchor fracture and/or mesh detachment) and device movement/migration in patients implanted with the Barricaids with anchors from two different suppliers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Disc Herniation Annular Tear of Lumbar Disc

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients implanted with vendor B anchor

Follow up per standard of care

Intervention Type OTHER

Patients will come in 2 years post implantation and receive standard examinations

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Follow up per standard of care

Patients will come in 2 years post implantation and receive standard examinations

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Each site will enroll all patients who were implanted with a Barricaid with an anchor manufactured by the second manufacturer.
* Patients must be 18 years of age or older and able to understand and consent to participate in the study.

Exclusion Criteria

* Not defined
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Intrinsic Therapeutics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wirbelsäulenzentrum Bielefeld

Bielefeld, , Germany

Site Status

Klinikum Itzehoe

Itzehoe, , Germany

Site Status

Universitaetsklinikum Schleswig-Holstein

Kiel, , Germany

Site Status

Bonifatius Hospital Lingen

Lingen, , Germany

Site Status

UKM Marienhospital Steinfurt

Steinfurt, , Germany

Site Status

Orthopädie St.Gallen

Sankt Gallen, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EUBARD-CP-001-PMCFU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Titanium vs. PEEK Fusion Devices in 1 Level TLIF
NCT05691062 ENROLLING_BY_INVITATION PHASE4